Yuyan Wei

449 total citations
18 papers, 360 citations indexed

About

Yuyan Wei is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yuyan Wei has authored 18 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yuyan Wei's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Mechanisms and Therapy (2 papers). Yuyan Wei is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Mechanisms and Therapy (2 papers). Yuyan Wei collaborates with scholars based in China, United States and United Kingdom. Yuyan Wei's co-authors include Xiaolin Liu, Qifeng Yang, Ping Lin, Zhaojian Liu, Ruifen Dong, Beihua Kong, Kai Li, Lugang Huang, Yingwei Li and Yinuo Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and British Journal of Cancer.

In The Last Decade

Yuyan Wei

17 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuyan Wei China 11 246 117 89 51 50 18 360
Namita Chatterjee United States 10 235 1.0× 160 1.4× 97 1.1× 36 0.7× 55 1.1× 12 356
Vahideh Zarrin Iran 7 238 1.0× 153 1.3× 89 1.0× 38 0.7× 46 0.9× 9 405
Songhan Li China 7 217 0.9× 129 1.1× 86 1.0× 25 0.5× 41 0.8× 14 375
Jian Ni China 10 197 0.8× 83 0.7× 68 0.8× 24 0.5× 71 1.4× 29 378
Jeannette Huaman United States 6 155 0.6× 111 0.9× 73 0.8× 25 0.5× 48 1.0× 7 310
Marcela Cristina Robaina Brazil 12 314 1.3× 174 1.5× 79 0.9× 67 1.3× 45 0.9× 18 454
Qianjing Zhang China 10 279 1.1× 111 0.9× 78 0.9× 16 0.3× 67 1.3× 20 407
Bingjun Bai China 12 182 0.7× 108 0.9× 153 1.7× 40 0.8× 56 1.1× 26 424

Countries citing papers authored by Yuyan Wei

Since Specialization
Citations

This map shows the geographic impact of Yuyan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyan Wei more than expected).

Fields of papers citing papers by Yuyan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyan Wei. The network helps show where Yuyan Wei may publish in the future.

Co-authorship network of co-authors of Yuyan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyan Wei. A scholar is included among the top collaborators of Yuyan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyan Wei. Yuyan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pan, Xiuyi, Linmao Zheng, Mengxin Zhang, et al.. (2025). Fumarate activates the IL-6/JAK/STAT3 pathway by inhibiting KDM4C-mediated H3K36me3 demethylation in FH-knockdown renal cancer cells. British Journal of Cancer. 133(11). 1611–1624.
2.
Wei, Yuyan, Fengying Liu, Xiaoting Liu, et al.. (2024). Artesunate disrupts ribosome RNA biogenesis and inhibits ovarian cancer growth by targeting FANCA. Phytomedicine. 136. 156333–156333. 7 indexed citations
3.
4.
Huang, Zhuo, Ying Tang, Yuyan Wei, et al.. (2023). Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer. Journal of Clinical Medicine. 12(10). 3362–3362. 2 indexed citations
5.
Zheng, Linmao, Xingming Zhang, Xiuyi Pan, et al.. (2023). AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma. Modern Pathology. 36(11). 100303–100303. 16 indexed citations
6.
Liu, Hongyan, et al.. (2022). Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomedicine & Pharmacotherapy. 157. 114065–114065. 31 indexed citations
7.
8.
Li, Jun, Jie Ao, Kai Li, et al.. (2016). ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma. Cell Death and Disease. 7(10). e2428–e2428. 16 indexed citations
9.
Liu, Xiaolin, Wenjing Zhang, Yuyan Wei, et al.. (2016). Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis.. PubMed. 6(2). 249–59. 19 indexed citations
10.
Wei, Yuyan, Kai Li, Shaohua Yao, et al.. (2016). Loss ofZNF32augments the regeneration of nervous lateral line system through negative regulation ofSOX2transcription. Oncotarget. 7(43). 70420–70436. 7 indexed citations
11.
Li, Yan, et al.. (2015). Huaier aqueous extract inhibits cervical cancer cell proliferation via JNK/p38 pathway. International Journal of Oncology. 47(3). 1054–1060. 29 indexed citations
12.
Li, Yanyan, Le Zhang, Kai Li, et al.. (2015). ZNF32 inhibits autophagy through the mTOR pathway and protects MCF-7 cells from stimulus-induced cell death. Scientific Reports. 5(1). 9288–9288. 23 indexed citations
13.
Liu, Xiaolin, Ruifen Dong, Yuyan Wei, et al.. (2015). MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition. Tumor Biology. 36(6). 4261–4269. 14 indexed citations
14.
Li, Kai, Bo Gao, Jun Li, et al.. (2015). ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription. Oncotarget. 6(35). 38107–38126. 31 indexed citations
15.
Dong, Ruifen, Xiaolin Liu, Yingwei Li, et al.. (2014). miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. Oncotarget. 5(21). 10816–10829. 88 indexed citations
16.
Li, Jun, Le Zhang, Jie Zhang, et al.. (2012). Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Carcinogenesis. 34(3). 658–666. 41 indexed citations
17.
Wei, Yuyan, Jie Zhang, Kai Li, et al.. (2012). Establishment of a monoclonal antibody against a peptide of the novel zinc finger protein ZNF32 proved to be specific and sensitive for immunological measurements. Medical Science Monitor. 18(5). BR167–BR173. 5 indexed citations
18.
Li, Kai, Yuyan Wei, Jie Zhang, et al.. (2012). Cytoplasmic expression, antibody production, and characterization of the novel zinc finger protein 637. Applied Microbiology and Biotechnology. 97(2). 741–749. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Namita Chatterjee Breakdown of academic impact, for papers by Vahideh Zarrin Breakdown of academic impact, for papers by Songhan Li Breakdown of academic impact, for papers by Jian Ni Breakdown of academic impact, for papers by Jeannette Huaman Breakdown of academic impact, for papers by Marcela Cristina Robaina Breakdown of academic impact, for papers by Qianjing Zhang Breakdown of academic impact, for papers by Bingjun Bai
Rankless by CCL
2026